Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    16278407 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
Condition: Brain and Central Nervous System Tumors
Intervention: Drug: gefitinib

Indicates status has not been verified in more than two years